Winners Crowned!
Health Industry Hub Catalysts for Change Awards 2023
What an incredible celebration across the pharma, medtech, biotech and diagnostics sectors on the 1st November!
The Health Industry Hub Catalysts for Change Awards 2023 was a recognition of the remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare across the entire patient journey.
A huge congratulations to all the WINNERS
Outstanding Policy Conversations
- J&J MedTech
Advocacy Champion
- hearts4heart and Dr Michael Davis
Excellence in Collaboration
- Bayer and Prostate Cancer Foundation of Australia (PCFA)
- Stryker and A/Prof Laetitia de Villiers
Excellence in Digital Health
- Viatris
Excellence in Innovation
- Janssen
ESG Champion
- Pfizer and Uncle Michael West
Inspirational Leadership
- AbbVie – Nathalie McNeil, Vice President and General Manager, AbbVie ANZ
Outstanding Medical Conversations
- AstraZeneca and Australian Diabetes Society (ADS)
STEM Champion
- Noxopharm
Visionary Leadership
- Boehringer Ingelheim – Dirk Otto, General Manager of Boehringer Ingelheim ANZ
- Medtronic – Geoff Martha, global Chairman & CEO of Medtronic
Corporate Communications Team of the Year
- Medtronic
Corporate Communications Individual of the Year
- Emma Boscheinen – BMS
PR Agency Individual of the Year
- Kirsten Bruce – VIVA! Communications
PR Agency Team of the Year
- WE Communications
Interview of the Year
- AbbVie – Nathalie McNeil, Vice President and General Manager, AbbVie ANZ
Thank you to Health Industry Hub Awards‘
GOLD SPONSORS
Medical
NSW Health to settle ‘largest’ class action
A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]
MoreNews & Trends - Pharmaceuticals
Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap
Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]
MoreNews & Trends - Pharmaceuticals
AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases
Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]
MoreNews & Trends - Pharmaceuticals
PBAC recommendation to reshape prescribing in heart failure
Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]
More